NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant ...

NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: SCPS) (“Scopus” or the “Company”) today announced that it has filed an amendment to the Current Report on Form 8 ...

Scopus BioPharma has filed to raise $6 million in an IPO. The firm is advancing treatment candidates for lymphoma and systemic sclerosis. SCPS is thinly capitalized and is still at pre-Phase 1 ...

NEW YORK, April 26, 2021 /PRNewswire/ — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced the submission of an investigational new drug application (“IND”) to the United States Food ...

Short interest in Scopus BioPharma Inc (OTC:SCPS) decreased during the last reporting period, falling from 10.51K to 10.51K. This put 0.03% of the company's publicly available shares short.

NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for ...

Explore Scopus BioPharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SCPS. Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 ...

Scopus BioPharma (SCPS) - Shares of the company gained over 10% in after-hours trading on Wednesday after finishing 7% higher in its debut as a public company. The drugmaker earlier priced its $2. ...

(RTTNews) - Shares of Scopus BioPharma Inc. (SCPS) are surging over 70% on Wednesday morning after despite no stock-related new release from the company. SCPS is currently trading at $22.28 ...

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases ...